Teams Selected by ARPA-H to Develop Patient-Specific Bioprinted Organs
The Advanced Research Projects Agency for Health (ARPA-H) has announced the first recipients of its Personalized Regenerative Immunocompetent Nanotechnology Tissue (PRINT) program. The selected research teams from Carnegie Mellon University, Wake Forest University, the Wyss Institute, University of California San Diego, and University of Texas Southwestern Medical Center will develop advanced bioprinted organs, including livers and kidneys, designed to function without immunosuppressive drugs by using patient-specific cells or those from biobanks.